Our flagship product targets the deepest layer of the epigenome - DNA methylation. It uses our proprietary MeTLAND technology to capture methylation patterns across the genome in a way that is cheaper, more data-rich and easier to implement compared to existing alternatives.
Interested in MeTLAND®?
Try our Early Access Program
Our early access partners can:
Benchmark MeTLAND side-by-side with their current method
Test challenging or low-input samples
Generate high-complexity methylation libraries with fast turnaround
Provide feedback that shapes the first commercial release
This program is designed for teams who need reliable, scalable methylation profiling and want early access to next-generation epigenomic chemistry.